article thumbnail

Assessment of Project ECHO(R) Opioid Use Disorder Sessions for Primary Care Teams [Education and training]

Annals of Family Medicine

Context: In the US, opioid use disorder (OUD) presents significant and urgent public health concerns. Unfortunately, most individuals suffering from OUD do not have access to necessary care. A critical shortage of clinicians who specialize in treating patients with OUD exacerbates this issue.

article thumbnail

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

The context: Immigrants, particularly those moving from lower to higher-income countries, often exhibit a heightened susceptibility to non-communicable diseases, such as Type 2 diabetes (T2D), which may manifest at an earlier age and present with different complications compared to the native population. 0.83, HR 0.70; 95% CI 0.65-0.76,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy

GeriPal

A year ago we did our first “Deprescribing Super Special”. Next up, we chat with Liz Bayliss about her JAMA IM article that studied whether increasing awareness about deprescribing prior to primary care visits can reduce the use of potentially inappropriate long-term medications for individuals with cognitive impairment. Right, Alex?

article thumbnail

Episode 181: Antiracism in Medicine Series – Episode 9 – Moving Towards Antiracism in Medical Education

The Clinical Problem Solvers

[link] Summary In this special episode of the Antiracism in Medicine Series, originally recorded for the 2021 Society of General Internal Medicine Annual Meeting, the CPSolvers Antiracism team discusses what must be done to make medical education more antiracist. Credits Written and produced by: Dereck Paul, MD, MS; Chioma Onuoha, Utibe R.

article thumbnail

Well Isn’t that Special: An Assessment of the Special Control Associated with Simple Point of Care COVID-19 Antigen Tests

FDA Law Blog

In this blog we examine the Special Controls put in place to mitigate false results, incorrect interpretation of results, and incorrect operation of the device. The Special Controls are silent on what would constitute appropriate levels of evidence necessary to satisfy this criterion. analytical, clinical and stability).

article thumbnail

Be The Market: How Doctors Should Invest Their Money

The Motivated MD

How, then, can any physician find the time to research individual companies and make educated decisions on which publicly traded businesses are undervalued? Instead of investing in individual stocks, why not buy all the most economically impactful stocks in a proportion that reflects an index of the market? We simply cannot.

Finance 52
article thumbnail

No Walk in the Park: JAMA Editorial Calls for More Park Prosecutions; We Disagree

FDA Law Blog

The drug and medical device industries present particularly compelling arenas in which to pursue deterrence through such prosecution because misconduct can carry high levels of public risk. It’s another thing entirely to prosecute individuals who were not involved in the misfeasance and were unaware of the alleged violations.